RecruitingNCT05040178

An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics

Studying Disorder of branched-chain amino acid metabolism

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
RECORDATI GROUP
Principal Investigator
William Ludlum, MD
Recordati Rare Diseases Inc
Intervention
Carglumic Acid(drug)
Enrollment
20 enrolled
Eligibility
All sexes
Timeline
20222032

Study locations (5)

Collaborators

Target PharmaSolutions, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05040178 on ClinicalTrials.gov

Other trials for Disorder of branched-chain amino acid metabolism

Additional recruiting or active studies for the same condition.

See all trials for Disorder of branched-chain amino acid metabolism

← Back to all trials